.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Charles M. Farber, MD, PhD

Articles

The Clinical and Economic Value of Rituximab for the Treatment of Hematologic Malignancies

March 15th 2011

Rituximab is a humanized monoclonal antibody that is used for the treatment of a wide variety of B-cell-derived hematologic malignancies